Shroom to grow

摘要

Christian angermayer has never drunk alcohol nor smoked a cigarette. He is, however, a fan of ketamine. In January atai Life Sciences, the German biotech company he founded last year, acquired a majority stake in Perception Neuroscience, a biopharmaceutical firm from New York which is developing a medication for pys-chiatric conditions like depression from the drug, which is illegal in parts of the world (though not in America). Along with Peter Thiel, a veteran Silicon Valley investor known for headline-grabbing bets, atai has also backed compass Pathways, a startup in London aiming to be the first legal provider of psilocybin, which gives mushrooms their magic.